Skip to main content
Search
Main Navigation
Home
News
Current Index
Topics
Research leaders
Supplements
Further analysis
Client
services
About
×
Search category
Institutions
Countries/territories
Topics
Article
Search
Search
Search
Search
Time frame: 1 May 2025 - 30 April 2026
Institution search supports local language names.
(Examples: Universidad Autónoma de Madrid
,
筑波大学)
View the latest institution rankings
View the latest Country/territory rankings
View topics
Home
Articles
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.
Journal:
Journal of Clinical Oncology
Published:
2026-04-15
DOI
:
10.1200/jco-25-01137
Affiliations:
33
Authors:
64
Go to article
Institutions
Authors
Share
Global Coalition for Adaptive Research (GCAR), United States of America (USA)
3.500000
0.11
University of Pittsburgh Medical Center (UPMC), United States of America (USA)
2.000000
0.06
Henry Ford Health System (HFHS), United States of America (USA)
1.333333
0.04
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
1.000000
0.03
Ohio State University Wexner Medical Center (OSUWMC), United States of America (USA)
1.000000
0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)
1.000000
0.03
University of Virginia (UVA), United States of America (USA)
1.000000
0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.03
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)
1.000000
0.03
Berry Consultants LLC, United States of America (USA)
1.000000
0.03
Herbert Irving Comprehensive Cancer Center (HICCC), United States of America (USA)
1.000000
0.03
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)
1.000000
0.03
The University of Alabama at Birmingham (UAB), United States of America (USA)
1.000000
0.03
Sylvester Comprehensive Cancer Center (Sylvester), UM, United States of America (USA)
1.000000
0.03
Yale University, United States of America (USA)
1.000000
0.03
University Hospital Zurich (UHZ), Switzerland
1.000000
0.03
UH Seidman Cancer Center, CWRU, United States of America (USA)
1.000000
0.03
Sunnybrook Health Sciences Centre, U of T, Canada
1.000000
0.03
Washington University in St. Louis (WUSTL), United States of America (USA)
1.000000
0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.03
Mayo Clinic's Campus in Florida, United States of America (USA)
1.000000
0.03
Stanford University School of Medicine, United States of America (USA)
1.000000
0.03
Mass General Brigham, United States of America (USA)
1.000000
0.03
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)
1.000000
0.03
University of California, San Francisco (UCSF), United States of America (USA)
1.000000
0.03
Piedmont Healthcare, United States of America (USA)
1.000000
0.03
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
1.000000
0.03
University of California, Los Angeles (UCLA), United States of America (USA)
0.500000
0.02
Michigan State University (MSU), United States of America (USA)
0.333333
0.01
Wayne State University, United States of America (USA)
0.333333
0.01
Interested in
Oncology and Carcinogenesis
?
News
News home
News
Comment
Data insights
Dataviz
Careers
Q+A
Archive
Current Index
Institution rankings
Institution benchmarking
Institution collaboration
Country/territory rankings
Country/territory benchmarking
Country/territory collaboration
Data visualizations
Articles
Research highlights
Data products survey
Topics
Topic explorer
Nature Index topics
Leading institutions by topic
Leading countries/territories by topic
Research leaders
Research leaders home
2026 Research Leaders
2025 Research Leaders
2024 Research Leaders
2023 Research Leaders
2022 Research Leaders
2021 Research Leaders
2020 Research Leaders
2019 Research Leaders
2018 Research Leaders
2017 Research Leaders
2016 Research Leaders
Supplements
Nature Index supplements
Further analysis
Author gender ratio
Applied sciences
Nature Strategy Reports
Client services
Client services
Advertising
Research management
Brochure
About
Mission statement
A brief guide to the Nature Index
How to use the Nature Index
FAQ
About Nature Research Intelligence Topics
Institutions A-Z
Glossary of terms
Follow us on Twitter
Follow us on Facebook